In compliance with the provisions of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011, Emmessar Biotech & Nutrition has informed that Emmessar Technologies, Promoter Company, have acquired 6,686 equity shares of the company between November 18, 2023 and November 21 2022, through open market. The intimation was received by the Company on 23-12-2022. It has enclosed the disclosure under Regulation, 29(2) of the of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011.
The above information is a part of company’s filings submitted to BSE.
